The Effect of Methylprednisolone on the Reversal Time of Rocuronium by Sugammadex in the Pediatric Patient Group

NCT06623370 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Sugammadex Reversal Time
Muscle Weakness

Interventions

DRUG: methylprednisolone
OTHER: Saline (NaCl 0,9 %) (placebo)

Sponsor

Konya City Hospital